Drug Trial Radar · NCT07226206
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5
Planned (sponsor's estimate)
Start
Sep 8, 2026
Primary completion
Apr 30, 2032
Study completion Apr 30, 2032
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Nov 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A.
Conditions
- Hemophilia A
Interventions
SPK-8011QQDrug
Participants will receive IV SPK-8011QQ
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of participants with adverse events (AEs)Time frame: Up to approximately 5 years
- Severity of AEs as determined according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) v5.0 grading scaleTime frame: Up to approximately 5 years
- Incidence of adverse events of special interest (AESIs)Time frame: Up to approximately 5 years
- Incidence of serious adverse events (SAEs)Time frame: Up to approximately 5 years
- Incidence of treatment-related AEsTime frame: Up to approximately 5 years
- Number of participants with abnormal laboratory valuesTime frame: Up to approximately 5 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Center for Inherited Blood Disorders
Orange, California · Recruiting
University of California San Francisco
San Francisco, California · Recruiting
Kaiser Permanente
Vallejo, California · Recruiting
Yale School of Medicine
New Haven, Connecticut · Recruiting
Newark Beth Israel Medical Center
Newark, New Jersey · Recruiting
New York Presbyterian Hospital - Weill-Cornell
New York, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.